Additionally, it has been identified as predictive of the response to adjuvant chemotherapy, suggesting the potential of cathepsin S to serve both as a prognostic indicator and as a novel biomarker for predicting the response to treatments in colorectal cancer patients [28]. The gene discussed is CTSS; the disease is colorectal cancer.